The relevance of SRF protein expression in prostate cancer patients was demonstrated in several published studies [7,12,13,14], highlighting the clinical relevance of this protein and the possibility of using it as a therapeutic target and a disease biomarker. The gene discussed is SRF; the disease is prostate carcinoma.